COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey / Matucci A., Caminati M., Vivarelli E., Vianello A., Micheletto C., Menzella F., Crisafulli E., Passalacqua G., Bagnasco D., Lombardi C., Parronchi P., Crivellaro M.A., Chieco-Bianchi F., Rita Marchi M., Guarnieri G., Cosmi L., Rossi O., Almerigogna F., Senna G., Vultaggio A.. - In: ALLERGY. - ISSN 0105-4538. - ELETTRONICO. - (2021), pp. 0-0. [10.1111/all.14516]
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey
Matucci A.;Parronchi P.;Cosmi L.;Rossi O.;Almerigogna F.;Vultaggio A.
2021
Abstract
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey
| File | Dimensione | Formato | |
|---|---|---|---|
|
vultaggio allergy 2020.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
317.53 kB
Formato
Adobe PDF
|
317.53 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
